O. Jung Kwon

O. Jung Kwon

Auto-generated profile, based on publicly available information

O. Jung Kwon

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
HPHye Kyeong Park
Hye Kyeong Park
WKWon-Jung Koh
Won-Jung Koh
TSTae Sun Shim
Tae Sun Shim
OKO Jung Kwon
O Jung Kwon
Park HK, et al. Yonsei Med J. 2010 Jul;51(4):552-556. http://dx.doi.org/10.3349/ymj.2010.51.4.552

1 May 2006
Verified
Journal Article
Closed access
Kyeongman JeonKyeongman Jeon
Kyeongman Jeon
HKHojoong Kim
Hojoong Kim
CYChang-Min Yu
Chang-Min Yu
WKWon-Jung Koh
Won-Jung Koh
GSGee Young Suh
Gee Young Suh
OKO Jung Kwon
O Jung Kwon

23 July 2013 in Critical Care
Verified
Journal Article
Open access
PDF file
HYHongseok Yoo
Hongseok Yoo
GSGee Young Suh
Gee Young Suh
Byeong-Ho JeongByeong-Ho Jeong
Byeong-Ho Jeong
SLSo Yeon Lim
So Yeon Lim
MCMan Pyo Chung
Man Pyo Chung
Kyeongman JeonKyeongman Jeon
Kyeongman Jeon
Introduction: Although previous studies have reported etiologies, diagnostic strategies, and outcomes of acute respiratory failure (ARF) in cancer patients, few studies investigated ARF in cancer patients presenting with diffuse pulmonary infiltrates. Methods: This was a retrospective observational study of 214 consecutive cancer patients with diffuse pulmonary infiltrates on chest radiography admitted to the oncology medical intensive care unit for acute respiratory failure between July 2009 and June 2011. Results: After diagnostic investigations including bronchoalveolar lavage in 160 (75%) patients, transbronchial lung biopsy in 75 (35%), and surgical lung biopsy in 6 (3%), the etiologies of diffuse pulmonary infiltrates causing ARF were identified in 187 (87%) patients. The most common etiology was infection (138, 64%), followed by drug-induced pneumonitis (13, 6%) and metastasis (12, 6%). Based on the etiologic diagnoses, therapies for diffuse pulmonary infiltrates were subsequently modified in 99 (46%) patients. Diagnostic yield (46%, 62%, 85%, and 100%; P for trend < 0.001) and frequency of therapeutic modifications (14%, 37%, 52%, and 100%; P for trend < 0.001) were significantly increased with additional invasive tests. Patients with therapeutic modification had a 34% lower in-hospital mortality rate than patients without therapeutic modification (38% versus 58%, P = 0.004) and a similar difference in mortality rate was observed up to 90 days (55% versus 73%, Log-rank P = 0.004). After adjusting for potential confounding factors, therapeutic modification was still significantly associated with reduced in-hospital mortality (adjusted OR 0.509, 95% CI 0.281-0.920). Conclusions: Invasive diagnostic tests, including lung biopsy, increased diagnostic yield and caused therapeutic modification that was significantly associated with better outcomes for diffuse pulmonary infiltrates causing ARF in cancer patients.

2 October 2009 in Microbial Pathogenesis
Verified
Journal Article
Closed access
HSHosung Sohn
Hosung Sohn
Hwa-jung KimHwa-jung Kim
Hwa-jung Kim
JKJin Man Kim
Jin Man Kim
OKO. Jung Kwon
O. Jung Kwon
WKWon-Jung Koh
Won-Jung Koh
SSSung Jae Shin
Sung Jae Shin

1 August 2005 in American Journal of Roentgenology
Verified
Journal Article
Closed access
TKTae Sung Kim
Tae Sung Kim
HKHong Kwan Kim
Hong Kwan Kim
WKWon-Jung Koh
Won-Jung Koh
JCJae Chol Choi
Jae Chol Choi
MCMyung Jin Chung
Myung Jin Chung
SCSemin Chong
Semin Chong
OBJECTIVE. Our objective was to assess the CT findings for endobronchial actinomycosis associated with broncholithiasis. CONCLUSION. Endobronchial actinomycosis associated with broncholithiasis manifests as a proximal obstructive calcified endobronchial nodule associated with distal postobstructive pneumonia of the involved lobe or segment on CT. The possibility of endobronchial actinomycosis should be entertained when broncholithiasis is seen on CT in tuberculosis-endemic areas.

1 May 2012 in Radiology
Verified
Journal Article
Closed access
AVAkash Verma
Akash Verma
HPHye Yun Park
Hye Yun Park
SLSo Yeon Lim
So Yeon Lim
Sang-Won UmSang-Won Um
Sang-Won Um
WKWon-Jung Koh
Won-Jung Koh
HKHojoong Kim
Hojoong Kim
To evaluate whether air pockets (tracheobronchial air columns in the space between the outer surface of the stent and the adjacent airway wall) discernible at computed tomography (CT) can help optimize the time of stent removal in patients with posttuberculosis tracheobronchial stenosis (PTTS). The study was approved by the institutional review board, and informed consent was obtained from all patients. Data from 41 patients (five men, 36 women) with a median age of 39 years (range, 21-64 years) who underwent silicone stent placement owing to PTTS, followed by CT and stent removal 6-12 months after clinical stabilization, were investigated retrospectively. Two radiologists determined whether the extent of air pockets on CT scans was associated with clinical success, which was defined as maintenance of a prosthesis-free airway for more than 2 years after stent removal. Radiologic features were compared for outcome by using a Wilcoxon two-sample test or Fisher exact test. Stents were removed successfully in 31 patients (76%). Air pockets longer than 1 cm or longer than 2 cm were associated with successful stent removal (P = .04 and P = .006, respectively). The sensitivity and specificity of air pocket length in the prediction of successful stent removal were 84% and 50%, respectively, for air pockets longer than 1 cm and 68% and 70% for air pockets longer than 2 cm. The extent of air pockets at chest CT shows correlation with the success of stent removal, indicates regression of stenosis, and may help guide the optimal time for stent removal.